Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male

Cell Metabolism

Volumn 23, Issue 5, 2016, Pages 837-851

  Navarro, Guadalupe ^b   Xu, Weiwei ^a   Jacobson, David A ^c   Wicksteed, Barton ^d   Allard, Camille ^a   Zhang, Guanyi ^e   De Gendt, Karel ^f   Kim, Sung Hoon ^g   Wu, Hongju ^a   Zhang, Haitao ^e   Verhoeven, Guido ^f   Katzenellenbogen, John A ^g   Mauvais Jarvis, Franck ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Chicago ^*  (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INCRETIN; GLUCOSE; INSULIN; TESTOSTERONE;

AGING; ANDROGEN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; HUMAN CELL; INSULIN RELEASE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; CELL NUCLEUS; DEFICIENCY; DRUG EFFECT; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIC AMP; GLUCOSE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MALE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 84964589443     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.03.015     Document Type: Article

References (50)

1. B. Ahrén Autonomic regulation of islet hormone secretion - implications for health and disease Diabetologia 43 2000 393 410
2. S.J. Ashcroft Glucoreceptor mechanisms and the control of insulin release and biosynthesis Diabetologia 18 1980 5 15
3. S. Basaria, D.C. Muller, M.A. Carducci, J. Egan, and A.S. Dobs Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy Cancer 106 2006 581 588
4. N. Bruchovsky, and J.D. Wilson The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate J. Biol. Chem. 243 1968 5953 5960
5. C.S. Chang, J. Kokontis, and S.T. Liao Molecular cloning of human and rat complementary DNA encoding androgen receptors Science 240 1988 324 326
6. K. De Gendt, J.V. Swinnen, P.T. Saunders, L. Schoonjans, M. Dewerchin, A. Devos, K. Tan, N. Atanassova, F. Claessens, C. Lécureuil, and et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis Proc. Natl. Acad. Sci. U S A 101 2004 1327 1332
7. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
8. J.M. Egan, G.S. Meneilly, J.F. Habener, and D. Elahi Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state J. Clin. Endocrinol. Metab. 87 2002 3768 3773
9. W. Fan, T. Yanase, M. Nomura, T. Okabe, K. Goto, T. Sato, H. Kawano, S. Kato, and H. Nawata Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion Diabetes 54 2005 1000 1008
10. F. Fehse, M. Trautmann, J.J. Holst, A.E. Halseth, N. Nanayakkara, L.L. Nielsen, M.S. Fineman, D.D. Kim, and M.A. Nauck Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes J. Clin. Endocrinol. Metab. 90 2005 5991 5997
11. R. Göke, H.C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, and B. Göke Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells J. Biol. Chem. 268 1993 19650 19655
12. S.M. Haffner, M. Laakso, H. Miettinen, L. Mykkänen, P. Karhapää, and D.L. Rainwater Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men J. Clin. Endocrinol. Metab. 81 1996 3697 3701
13. C.H. Ho, H.J. Yu, C.Y. Wang, F.S. Jaw, J.T. Hsieh, W.C. Liao, Y.S. Pu, and S.P. Liu Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome PLoS ONE 8 2013 e74173
14. M. Inaba, Y. Otani, K. Nishimura, N. Takaha, A. Okuyama, M. Koga, J. Azuma, I. Kawase, and S. Kasayama Marked hyperglycemia after androgen-deprivation therapy for prostate cancer and usefulness of pioglitazone for its treatment Metabolism 54 2005 55 59
15. D.A. Jacobson, C.R. Weber, S. Bao, J. Turk, and L.H. Philipson Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate J. Biol. Chem. 282 2007 7442 7449
16. P.M. Jones, J. Stutchfield, and S.L. Howell Effects of Ca2+ and a phorbol ester on insulin secretion from islets of Langerhans permeabilised by high-voltage discharge FEBS Lett. 191 1985 102 106
17. K.A. Kaihara, L.M. Dickson, D.A. Jacobson, N. Tamarina, M.W. Roe, L.H. Philipson, and B. Wicksteed β-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion Diabetes 62 2013 1527 1536
18. N.L. Keating, A. O'Malley, S.J. Freedland, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer J. Natl. Cancer Inst. 104 2012 1518 1523
19. K.T. Khaw, and E. Barrett-Connor Lower endogenous androgens predict central adiposity in men Ann. Epidemiol. 2 1992 675 682
20. P.E. Lacy, M.M. Walker, and C.J. Fink Perifusion of isolated rat islets in vitro. Participation of the microtubular system in the biphasic release of insulin Diabetes 21 1972 987 998
21. J.Y. Lee, M. Ristow, X. Lin, M.F. White, M.A. Magnuson, and L. Hennighausen RIP-Cre revisited, evidence for impairments of pancreatic β-cell function J. Biol. Chem. 281 2006 2649 2653
22. B.J. Lin, and R.E. Haist Effects of some modifiers of insulin secretion on insulin biosynthesis Endocrinology 92 1973 735 742
23. Z. Liu, V. Stanojevic, S. Avadhani, T. Yano, and J.F. Habener Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival Diabetologia 54 2011 2067 2076
24. D.B. Lubahn, D.R. Joseph, P.M. Sullivan, H.F. Willard, F.S. French, and E.M. Wilson Cloning of human androgen receptor complementary DNA and localization to the X chromosome Science 240 1988 327 330
25. P. Marchetti, R. Lupi, M. Bugliani, C.L. Kirkpatrick, G. Sebastiani, F.A. Grieco, S. Del Guerra, V. D'Aleo, S. Piro, L. Marselli, and et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets Diabetologia 55 2012 3262 3272
26. T. Matsumoto, M. Sakari, M. Okada, A. Yokoyama, S. Takahashi, A. Kouzmenko, and S. Kato The androgen receptor in health and disease Annu. Rev. Physiol. 75 2013 201 224
27. F. Mauvais-Jarvis Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity Trends Endocrinol. Metab. 22 2011 24 33
28. M.L. Mohler, C.E. Bohl, A. Jones, C.C. Coss, R. Narayanan, Y. He, D.J. Hwang, J.T. Dalton, and D.D. Miller Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit J. Med. Chem. 52 2009 3597 3617
29. S. Morimoto, M.A. Cerbón, A. Alvarez-Alvarez, G. Romero-Navarro, and V. Díaz-Sánchez Insulin gene expression pattern in rat pancreas during the estrous cycle Life Sci. 68 2001 2979 2985
30. R. Nesher, E. Anteby, M. Yedovizky, N. Warwar, N. Kaiser, and E. Cerasi Beta-cell protein kinases and the dynamics of the insulin response to glucose Diabetes 51 Suppl 1 2002 S68 S73
31. J.Y. Oh, E. Barrett-Connor, N.M. Wedick, D.L. Wingard Rancho Bernardo Study Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study Diabetes Care 25 2002 55 60
32. D. Oropeza, N. Jouvet, L. Budry, J.E. Campbell, K. Bouyakdan, J. Lacombe, G. Perron, V. Bergeron, J.C. Neuman, H.K. Brar, and et al. Phenotypic characterization of MIP-CreERT1Lphi mice with transgene-driven islet expression of human growth hormone Diabetes 64 2015 3798 3807
33. N. Pitteloud, V.K. Mootha, A.A. Dwyer, M. Hardin, H. Lee, K.F. Eriksson, D. Tripathy, M. Yialamas, L. Groop, D. Elahi, and F.J. Hayes Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men Diabetes Care 28 2005 1636 1642
34. J. Prescott, and G.A. Coetzee Molecular chaperones throughout the life cycle of the androgen receptor Cancer Lett. 231 2006 12 19
35. S. Schoch, G. Cibelli, and G. Thiel Neuron-specific gene expression of synapsin I. Major role of a negative regulatory mechanism J. Biol. Chem. 271 1996 3317 3323
36. R. Snoek, P.S. Rennie, S. Kasper, R.J. Matusik, and N. Bruchovsky Induction of cell-free, in vitro transcription by recombinant androgen receptor peptides J. Steroid Biochem. Mol. Biol. 59 1996 243 250
37. W.J. Song, M. Seshadri, U. Ashraf, T. Mdluli, P. Mondal, M. Keil, M. Azevedo, L.S. Kirschner, C.A. Stratakis, and M.A. Hussain Snapin mediates incretin action and augments glucose-dependent insulin secretion Cell Metab. 13 2011 308 319
38. R.K. Stellato, H.A. Feldman, O. Hamdy, E.S. Horton, and J.B. McKinlay Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study Diabetes Care 23 2000 490 494
39. J. Tiano, and F. Mauvais-Jarvis Selective estrogen receptor modulation in pancreatic β-cells and the prevention of type 2 diabetes Islets 4 2012 173 176
40. J.P. Tiano, and F. Mauvais-Jarvis Importance of oestrogen receptors to preserve functional β-cell mass in diabetes Nat. Rev. Endocrinol. 8 2012 342 351
41. J.P. Tiano, and F. Mauvais-Jarvis Molecular mechanisms of estrogen receptors' suppression of lipogenesis in pancreatic β-cells Endocrinology 153 2012 2997 3005
42. J.P. Tiano, V. Delghingaro-Augusto, C. Le May, S. Liu, M.K. Kaw, S.S. Khuder, M.G. Latour, S.A. Bhatt, K.S. Korach, S.M. Najjar, and et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents β cell failure in rodent models of type 2 diabetes J. Clin. Invest. 121 2011 3331 3342
43. W.D. Tilley, M. Marcelli, J.D. Wilson, and M.J. McPhaul Characterization and expression of a cDNA encoding the human androgen receptor Proc. Natl. Acad. Sci. U S A 86 1989 327 331
44. T. Visakorpi, E. Hyytinen, P. Koivisto, M. Tanner, R. Keinänen, C. Palmberg, A. Palotie, T. Tammela, J. Isola, and O.P. Kallioniemi In vivo amplification of the androgen receptor gene and progression of human prostate cancer Nat. Genet. 9 1995 401 406
45. B. Wicksteed, M. Brissova, W. Yan, D.M. Opland, J.L. Plank, R.B. Reinert, L.M. Dickson, N.A. Tamarina, L.H. Philipson, A. Shostak, and et al. Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain Diabetes 59 2010 3090 3098
46. W.P. Wong, J.P. Tiano, S. Liu, S.C. Hewitt, C. Le May, S. Dalle, J.A. Katzenellenbogen, B.S. Katzenellenbogen, K.S. Korach, and F. Mauvais-Jarvis Extranuclear estrogen receptor-alpha stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis Proc. Natl. Acad. Sci. U S A 107 2010 13057 13062
47. I.C. Yu, H.Y. Lin, N.C. Liu, J.D. Sparks, S. Yeh, L.Y. Fang, L. Chen, and C. Chang Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression Diabetes 62 2013 411 423
48. Y.S. Zhu, L.Q. Cai, X. You, J.J. Cordero, Y. Huang, and J. Imperato-McGinley Androgen-induced prostate-specific antigen gene expression is mediated via dihydrotestosterone in LNCaP cells J. Androl. 24 2003 681 687
49. M. Zitzmann Testosterone deficiency, insulin resistance and the metabolic syndrome Nat. Rev. Endocrinol. 5 2009 673 681
50. M. Zitzmann, S. Faber, and E. Nieschlag Association of specific symptoms and metabolic risks with serum testosterone in older men J. Clin. Endocrinol. Metab. 91 2006 4335 4343